Donor-derived isolated del(20q) after hematopoietic stem cell transplantation: report of two cases and review of the literature

Hertenstein B, Hambach L, Bacigalupo A, Schmitz N, McCann S, Slavin S, Gratwohl A, Ferrant A, Elmaagacli A, Schwertfeger R, Locasciulli A, Zander A, Bornhauser M, Niederwieser D, Ruutu T (2005) Development of leukemia in donor cells after allogeneic stem cell transplantation—a survey of the European Group for Blood and Marrow Transplantation (EBMT). Haematologica 90:969–975 Boulton-Jones R, Parker A, Hepburn M, Bowen DT (2005) Secondary myelodysplasia of donor cell origin following nonmyeloablative sibling allogeneic stem cell transplantation. Bone Marrow Transplant 36:471–472 Komrokji R, Ifthikharuddin JJ, Felgar RE, Abboud CN, Wedow LA, Connaughton A, Bennett JM (2004) Donor cell myelodysplastic syndrome after allogeneic stem cell transplantation responding to donor lymphocyte infusion: case report and literature review. Am J Hematol 76:389–394 Shekhter-Levin S, Bloom EJ, Swerdlow SH, Sherer ME, Wald N, Gollin SM (1997) Acquired monosomy 7 in donor cells in a patient treated for acute lymphoblastic leukemia with bone marrow transplantation. Cancer Genet Cytogenet 95:190–197 Lowsky R, Fyles G, Minden M, Lipton J, Meharchand J, Tejpar I, Zipursky A, Messner H (1996) Detection of donor cell derived acute myelogenous leukaemia in a patient transplanted for chronic myelogenous leukaemia using fluorescence in situ hybridization. Br J Haematol 93:163–165 Abeliovich D, Yehuda O, Nagler A, Lerer I, Ben-Neriah S, Amar A, Or R (1996) Predominant 45, X,—Y karyotype in donor cells after allogeneic BMT: cytogenetic and molecular analysis. Cancer Genet Cytogenet 86:1–7 Okamoto T, Kanamaru A, Okada M, Kawaguchi K, Saheki K, Takatsuka H, Fujimori Y, Takemoto Y, Kohsaki M, Kakishita E (1996) Myelodysplastic changes in three cases within 100 days after allogeneic bone marrow transplantation. Int J Hematol 63:155–160 Sevilla J, Querol S, Molines A, Gonzalez-Vicent M, Balas A, Carrio A, Estella J, Angel Diaz M, Madero L (2006) Transient donor cell-derived myelodysplastic syndrome with monosomy 7 after unrelated cord blood transplantation. Eur J Haematol 77:259–263 Brunstein CG, Hirsch BA, Hammerschmidt D, McGlennen RC, Nguyen PL, Verfaillie CM (2002) Leukemia in donor cells after allogeneic hematopoietic stem cell transplant. Bone Marrow Transplant 29:999–1003 Daly AS, Kamel-Reid S, Lipton JH, Messner HA, Kiss TL, Chun K, Busque L, Chang H (2004) Acute leukemia of donor origin arising after stem cell transplantation for acute promyelocytic leukemia. Leuk Res 28:1107–1111 Lang Z, Dinndorf P, Ladisch S, Bayever E, Reaman G (2004) Chromosomal transformation in donor cells following allogeneic bone marrow transplantation. Bone Marrow Transplant 33:1253–1256 Kraut L, Trebeljahr G, Thiele B, Fauser AA (2005) Donor cell-derived myelodysplastic syndrome in a patient 7 years after unrelated allogeneic HLA-mismatched transplantation for Ph + chronic myeloid leukemia. Bone Marrow Transplant 36:737 Beck C, Humpe A, Harder S, Schmid M, Horst HA (2005) Myelodysplastic syndrome of donor origin subsequent to successful treatment of myeloid/NK-cell precursor leukaemia with allogeneic PBSCT: two very rare conditions in one patient. Ann Hematol 84:616–618 Sala-Torra O, Hanna C, Loken MR, Flowers ME, Maris M, Ladne PA, Mason JR, Senitzer D, Rodriguez R, Forman SJ, Deeg HJ, Radich JP (2006) Evidence of donor-derived hematologic malignancies after hematopoietic stem cell transplantation. Biol Blood Marrow Transplant 12:511–517 Wang E, Hutchinson CB, Huang Q, Lu CM, Crow J, Wang FF, Sebastian S, Rehder C, Lagoo A, Horwitz M, Rizzieri D, Yu J, Goodman B, Datto M, Buckley P (2011) Donor cell-derived leukemias/myelodysplastic neoplasms in allogeneic hematopoietic stem cell transplant recipients: a clinicopathologic study of 10 cases and a comprehensive review of the literature. Am J Clin Pathol 135:525–540 Erdag G, Meck JM, Meloni-Ehrig A, Matyakhina L, Donohue T, Srinivasan R, Mowrey P, Kelly J, Smith A, Childs R (2009) Long-term persistence of nonpathogenic clonal chromosome abnormalities in donor hematopoietic cells after allogeneic stem cell transplantation. Cancer Genet Cytogenet 190:125–130 Huh J, Tiu RV, Gondek LP, O'Keefe CL, Jasek M, Makishima H, Jankowska AM, Jiang Y, Verma A, Theil KS, McDevitt MA, Maciejewski JP (2011) Characterization of chromosome arm 20q abnormalities in myeloid malignancies using genome-wide single nucleotide polymorphism array analysis. Genes Chromosomes Cancer 49:390–399 Sole F, Luno E, Sanzo C, Espinet B, Sanz GF, Cervera J, Calasanz MJ, Cigudosa JC, Milla F, Ribera JM, Bureo E, Marquez ML, Arranz E, Florensa L (2005) Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes. Haematologica 90:1168–1178 Gupta R, Soupir CP, Johari V, Hasserjian RP (2007) Myelodysplastic syndrome with isolated deletion of chromosome 20q: an indolent disease with minimal morphological dysplasia and frequent thrombocytopenic presentation. Br J Haematol 139:265–268 Steensma DP, Dewald GW, Hodnefield JM, Tefferi A, Hanson CA (2003) Clonal cytogenetic abnormalities in bone marrow specimens without clear morphologic evidence of dysplasia: a form fruste of myelodysplasia? Leuk Res 27:235–242 Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, Thiele J, Vardiman JW (2008) WHO classification of tumours of haematopoietic and lymphoid tissue 4th edn. IARC, Lyon Tiu RV, Sekeres MA (2008) (2008) The role of AMG-531 in the treatment of thrombocytopenia in idiopathic thrombocytopenic purpura and myelodysplastic syndromes. Expert Opin Biol Ther 8(7):1021–1030 Hao S, Sanger W, Onciu M, Lai R, Schlette EJ, Medeiros LJ (2002) Mantle cell lymphoma with 8q24 chromosomal abnormalities: a report of 5 cases with blastoid features. Mod Pathol 15:1266–1272 Shaffer LG, Slovak ML, Campbell LJ (2009) An international system for human cytogenetic nomenclature: recommendations of the International Standing Committee on Human Cytogenetic Nomenclature S. Karger AG (Switzerland) Sun J, Yin CC, Cui W, Chen SS, Medeiros LJ, Lu G (2011) Chromosome 20q deletion: a recurrent cytogenetic abnormality in patients with chronic myelogenous leukemia in remission. Am J Clin Pathol 135:391–397 Fialkow PJ, Thomas ED, Bryant JI, Neiman PE (1971) Leukaemic transformation of engrafted human marrow cells in vivo. Lancet 1:251–255 Murata M, Ishikawa Y, Ohashi H, Terakura S, Ozeki K, Kiyoi H, Naoe T (2008) Donor cell leukemia after allogeneic peripheral blood stem cell transplantation: a case report and literature review. Int J Hematol 88:111–115 Wiseman DH (2011) Donor cell leukemia: a review. Biol Blood Marrow Transplant 17:771–789 Bacher U, Schnittger S, Kern W, Weiss T, Haferlach T, Haferlach C (2009) Distribution of cytogenetic abnormalities in myelodysplastic syndromes, Philadelphia negative myeloproliferative neoplasms, and the overlap MDS/MPN category. Ann Hematol 88:1207–1213 Reid AG, Swanton S, Grace C, Campbell LJ, Green AR, Nacheva EP (2003) Double Philadelphia masquerading as chromosome 20q deletion—a new recurrent abnormality in chronic myeloid leukaemia blast crisis. Br J Haematol 123:442–448 Medina J, Kantarjian H, Talpaz M, O'Brien S, Garcia-Manero G, Giles F, Rios MB, Hayes K, Cortes J (2003) Chromosomal abnormalities in Philadelphia chromosome-negative metaphases appearing during imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase. Cancer 98:1905–1911 Jabbour E, Kantarjian HM, Abruzzo LV, O'Brien S, Garcia-Manero G, Verstovsek S, Shan J, Rios MB, Cortes J (2007) Chromosomal abnormalities in Philadelphia chromosome negative metaphases appearing during imatinib mesylate therapy in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Blood 110:2991–2995 Medeiros BC, Chun K, Kamel-Reid S, Lipton J (2007) Inv (11)(p15q21) in donor-derived Ph-negative cells in a patient with chronic myeloid leukemia in relapse successfully treated with imatinib mesylate post allogeneic stem cell transplantation. Am J Hematol 82:758–760 Kurtin PJ, Dewald GW, Shields DJ, Hanson CA (1996) Hematologic disorders associated with deletions of chromosome 20q: a clinicopathologic study of 107 patients. Am J Clin Pathol 106:680–688 Niederwieser DW, Appelbaum FR, Gastl G, Gersdorf E, Meister B, Geissler D, Tratkiewicz JA, Thaler J, Huber C (1990) Inadvertent transmission of a donor's acute myeloid leukemia in bone marrow transplantation for chronic myelocytic leukemia. N Engl J Med 322:1794–1796 Dykes JH, Lindmark A, Lenhoff S, Winqvist I, Johansson B, Olofsson T, Olsson ML (2004) Autologous del(20q)-positive erythroid progenitor cells, re-emerging after DLI treatment of an MDS patient relapsing after allo-SCT, can provide a normal peripheral red blood cell count. Bone Marrow Transplant 33:559–563 Mielcarek M, Bryant E, Loken M, Torok-Storb B, Storb R (1999) Haemopoietic reconstitution by donor-derived myelodysplastic progenitor cells after haemopoietic stem cell transplantation. Br J Haematol 105:361–365 Mielcarek M, Bryant E, Loken M, Zaucha JM, Torok-Storb B, Storb R (2006) Long-term engraftment and clonal dominance of donor-derived del(20q) hematopoietic cells after allogeneic stem cell transplantation. Blood 107:1732–1733